Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?

DSpace Repository

Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?

Author: Schmidinger, Manuela; Resch, Irene; Fajkovic, Harun; Remzi, Mesut; Shariat, Shahrokh F.; Bedke, Jens
Tübinger Autor(en):
Bedke, Jens
Published in: Current Opinion in Urology (2021), Bd. 31, H. 3, S. 270-275
Verlagsangabe: Lippincott Williams & Wilkins
Language: English
Full text: http://dx.doi.org/10.1097/MOU.0000000000000874
ISSN: 1473-6586
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)